Kiniksa Pharmaceuticals International (KNSA) Payables (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Payables of $12.4 million for Q2 2026, up 38.5% from $8.96 million a year earlier but down 49.2% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International posted Payables of $2.03 million, down 0.5% from FY2024.
- Payables has a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
- By year, Payables came in at $2.04 million in FY2024 (-75.3%), $8.25 million in FY2023 (+4.4%), $7.9 million in FY2022 (+322.9%) and $1.87 million in FY2021 (+271.4%).
- Five-year quarterly Payables spans a low of $648,000 in Q2 2023 and a high of $24.4 million in Q1 2026.
- Year over year, Payables gained in three of the last seven quarters, with growth averaging 88.0%.
- The high point for year-over-year Payables in five years was Q3 2024 (growth of 722.9%); the low point was Q4 2024 (a decline of 75.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $24.4 million (Q1 2026), $2.03 million (Q4 2025) and $6.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.18 Bn | 4.92 Bn | 220.03 Mn | 12.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 24.40 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 8.96 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 8.33 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 5.63 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 648,000.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 7.90 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.65 Mn |
API Access
Kiniksa Pharmaceuticals International Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();